GlassScriptPhysician profile
Steven J Resnick
NPI 1972553816
$9,023.86
in general payments reported to CMS, 2019-2025
44 companies · $2,054 in 2025
The $2,054 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $380 · 2021: $1,276 · 2022: $1,693 · 2023: $1,630 · 2024: $1,385 · 2025: $2,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,068.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,359.06 | 2021-2025 | |
| Pfizer INC. | $699.96 | 2023-2025 | |
| Ge Healthcare | $478.40 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $463.24 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $442.38 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Allergan, INC. | $346.30 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $326.60 | 2019-2025 | Ultomiris |
| Biohaven Pharmaceuticals, INC. | $308.21 | 2021 | |
| Ucb, INC. | $249.95 | 2019-2023 | |
| Argenx US, INC. | $230.91 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.55 | 2023-2025 | Ofev |
| Amgen INC. | $204.04 | 2020-2021 | |
| Impel Pharmaceuticals INC. | $202.41 | 2022-2023 | Trudhesa |
| Astrazeneca Pharmaceuticals LP | $183.89 | 2021-2025 | Wainua, Andexxa |
| Lundbeck LLC | $171.24 | 2021-2025 | Vyepti |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Resnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.